Dare Bioscience Aktie
WKN DE: A2DU45 / ISIN: US23666P1012
14.07.2025 15:13:58
|
Daré Bioscience Shares Surge On Positive Phase 3 Data For Hormone-free Contraceptive Ovaprene
(RTTNews) - Shares of Daré Bioscience, Inc. (DARE) jumped more than 277.3400 per cent in the pre-market trading after the company announced positive interim safety and efficacy data for its ongoing Phase 3 trial of Ovaprene, a hormone-free, monthly intravaginal contraceptive.
If approved, Ovaprene would be the first FDA-approved product of its kind.
The shares are currently at 9.4900, up 6.9700 points or 277.3400 per cent on a volume of 8,234,525 shares, which had closed on Friday at $2.5150.
For comments and feedback, contact: editorial@rttnews.com

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Dare Bioscience Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |